Sequelae of COVID-19 infection
Conditions
Interventions
treatment group:pressing needle therapy
control group :sham pressing needle therapy
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) patients with negative detection of the nucleic acid turned from positive detection who met the criteria of mild and common type of diagnosis and treatment of new coronavirus pneumonia (trial version 9). (2) patients who were>=18 years old and =5, the score of GAD-7>=5, and the score of ISI>=8. (5) patients who have taken the same antidepressant or sedative and hypnotic drugs steadily for >= 4 weeks, or who have not taken antidepressant or sedative and hypnotic drugs. (6) patients who have not received pressing needle treatment. (7) patients voluntarily participated in the research and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) other cases of pneumonia such as infection with Epstein-barr virus, mycoplasma pneumoniae, Chlamydophila pneumoniae, mycobacterium tuberculosis, respiratory tract legionella pneumophila, etc. (2) patients with chronic respiratory tract disease, respiratory tract bacterial infection such as cough variant asthma, asthma, chronic obstructive pulmonary disease, bronchiectasis, interstitial pneumonia, organizing pneumonia, bronchitis, otitis media, sinusitis, tonsillitis, etc (3) congenital malformation of respiratory tract, abnormal development of lung, vasculitis, dermatomyositis, etc. (4) patients with severe heart, brain, liver, kidney system diseases, neuropsychiatric disease before infection with COVID-19. (5) patients with neuropsychiatric diseases, or with serious diseases that affect survival, such as blood diseases, tumors, cachexia, AIDS, etc. (6) pregnant women and lactating women. (7) patients who can not be treated by pressing needle such as skin redness, local skin lesions, metal or tape allergy, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient Health Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| Generalized Anxiety Disorder Scale;Insomnia Severity Index; | — |
Countries
China
Contacts
Public ContactWenjia Yang
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed